In the Boardroom
Refine Search
Biotechnology
Germany’s Ethris, a leader in mRNA-based therapeutics, is expanding its leadership team by the addition of Thomas Langenickel in the role of chief medical officer. 4 June 2019
Biotechnology
Atara Biotherapeutics, a US biotech specializing in T-cell immunotherapies for cancer, has named Pascal Touchon its new president, chief executive. 30 May 2019
Biotechnology
US biotech major Gilead Sciencestoday announced that Johanna Mercier will join the company as chief commercial officer, and will become a member of the company’s senior leadership team. 29 May 2019
Biotechnology
Cambridge, Massachusetts-based genome editing company Intellia Therapeutics has named Laura Sepp-Lorenzino as its new executive vice president and chief scientific officer. 28 May 2019
Biotechnology
Akrevia Therapeutics, a privately-held biopharma that was launched in September 2018 by Atlas and F-Prime, has now named its first chief executive. 23 May 2019
Biotechnology
Oncology heavyweight Robin Taylor has made the switch from VP level at big pharma to chief commercial officer at an emerging, multi-product biotech company. 23 May 2019
Biotechnology
US biotech firm bluebird bio has appointed Joanne Smith-Farrell to chief business officer. In this role, she will lead corporate development and strategy, and she will also continue to serve as our oncology franchise leader. 2 May 2019
Biotechnology
Swedish Orphan Biovitrum, the Nordic biotech company known as Sobi, has appointed Amy Pott as the new head of Sobi North America. She takes over effective today, replacing Rami Levin who is leaving Sobi. 30 April 2019
Biotechnology
British biotech Kymab has appointed Simon Sturge as its new chief executive, effective 1 May 2019. Mr Sturge will replace David Chiswell, who has been in the role since 2015. 10 April 2019
Biotechnology
French privately-held biotech firm Enterome Bioscience has named Jan Fagerberg its new chief medical officer and Catherine Mathis its chief development officer. 3 April 2019
Biotechnology
Daniel Welch, the man who previously headed up several biotechs that were sold to pharma majors over the past several years, has joined privately-held US biopharma company InCarda Therapeutics as executive chairman. 3 April 2019
Biotechnology
California, USA-based biopharma company Tenaya Therapeutics, which is focused on developing potentially curative treatments for heart disease, today announced that it has strengthened its leadership team. 14 March 2019
Biotechnology
California, USA-based Sangamo Therapeutics has announced the appointment of Jason Fontenot as senior vice president, cell therapy. 13 March 2019
Biotechnology
Privately-held Swiss biotech iOnctura has completed the line-up of its executive leadership team. 12 March 2019
Biotechnology
Dutch biopharma Kiadis Pharma today announced senior management appointments to further strengthen the company as it transitions into commercial stage. 6 March 2019
Biotechnology
UK-based biotech firm Emergex Vaccines today announces the appointment of Athanasios Papadopoulos as chief medical officer, effective March 1, 2019. 27 February 2019
Biotechnology
The UK’s BioIndustry Association (BIA) chairwoman Dr Jane Osbourn has announced this week that she is to leave AstraZeneca after 25 years with Cambridge Antibody Technology and MedImmune, where she is vice president R&D and site leader, the trade group announced yesterday. 19 February 2019
Biotechnology
UK-based Emergex Vaccines has secured a research and development (R&D) facility and hired a chief scientific officer (CSO). 18 February 2019
Biotechnology
Dutch biopharma Kiadis Pharma has announced the appointment of Robert Friesen as chief scientific officer (CSO) effective February 1, 2019. 5 February 2019
Biotechnology
Swiss pharma giant Roche’s Genentech subsidiary has appointed Alexander Hardy as chief executive, effective March 1, 2019. 25 January 2019
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze